Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Telemedicine and Telecare|December 19, 2001
Accuracy of tele-oncology compared with face-to-face consultation in head and neck cancer case conferencesJ Stalfors, S Edström, T Björk-Eriksson, et al.
Nano Letters|December 23, 2008
Doping limits of grown in situ doped silicon nanowires using phosphineHeinz Schmid, Mikael T Björk, Joachim Knoch, et al.
Urology|April 1, 1994
Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasiaT Björk, A Bjartell, P A Abrahamsson, et al.
Clinical Chemistry|July 1, 1989
Radioimmunoassay of beta-microseminoprotein, a prostatic-secreted protein present in sera of both men and womenP A Abrahamsson, C Andersson, T Björk, et al.
Nano Letters|August 31, 2011
Trap-assisted tunneling in Si-InAs nanowire heterojunction tunnel diodesCedric D Bessire, Mikael T Björk, Heinz Schmid, et al.
Urology|November 1, 1993
Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epitheliumA Bjartell, T Björk, M T Matikainen, et al.
Urology|February 11, 1998
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serumT Björk, B Ljungberg, T Piironen, et al.
The Journal of Urology|December 22, 1999
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serumC Becker, T Piironen, K Pettersson, et al.
Nano Letters|March 9, 2006
InAs1-xPx nanowires for device engineeringA I Persson, M T Björk, S Jeppesen, et al.
The Journal of Urology|November 24, 1999
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomyH Lilja, A Haese, T Björk, et al.
Pageof 5